Billionaire investor launches board fight at Athira, wants CEO replaced
By Svea Herbst-Bayliss BOSTON (Reuters) -Billionaire investor Richard (Ric) Kayne is seeking two board seats at Athira Pharma, arguing the biotech company needs a new chief executive officer to successfully guide its development of treatments for Alzheimer’s and other neurodegenerative diseases. Kayne, who founded private equity investment firm Kayne Anderson Capital Advisors, told Athira shareholders …
Billionaire investor launches board fight at Athira, wants CEO replaced Read More »